| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |